Royal Bank Of Canada Adamis Pharmaceuticals Corp Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.1 - $0.3 $3 - $10	36 Added 64.29%	92 $0
Q4 2022 Feb 14, 2023	BUY	$0.14 - $0.22 $7 - $12	56 New	56 $0
Q2 2022 Aug 15, 2022	SELL	$0.34 - $0.57 $1,700 - $2,849	-5,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.55 - $0.73 $2,750 - $3,650	5,000 New	5,000 $3,000
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.23 $11,399 - $24,600	-20,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.92 - $1.18 $18,400 - $23,600	20,000 New	20,000 $19,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.